[1]
Kollmannsberger, C. et al. 2012. Sunitinib therapy for metastatic renal cell carcinoma: recommendations for management of side effects. Canadian Urological Association Journal. 1, 2S (Dec. 2012). DOI:https://doi.org/10.5489/cuaj.67.